File(s) under permanent embargo
P2.03-044 OSCILLATE - Phase 2 Trial of Alternating Osimertinib with Gefitinib in Patients with EGFR-T790M Mutation Positive Advanced NSCLC
Version 2 2024-06-02, 15:09Version 2 2024-06-02, 15:09
Version 1 2023-03-17, 05:07Version 1 2023-03-17, 05:07
journal contribution
posted on 2024-06-02, 15:09 authored by B Solomon, P Kok, Ann LivingstoneAnn Livingstone, S Yip, C Brown, S Dawson, S Wong, N Pavlakis, M StocklerP2.03-044 OSCILLATE - Phase 2 Trial of Alternating Osimertinib with Gefitinib in Patients with EGFR-T790M Mutation Positive Advanced NSCLC
History
Journal
Journal of Thoracic OncologyVolume
12Pagination
S2144-S2144Publisher DOI
ISSN
1556-0864Language
enPublication classification
E3 Extract of paperTitle of proceedings
Journal of Thoracic OncologyIssue
11Publisher
Elsevier BVPublication URL
Usage metrics
Categories
Keywords
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC